Introduction {#s1}
============

As the population ages, the number of older people with cognitive decline is increasing. The transition from normal cognitive aging to mild cognitive impairment (MCI) and subsequent dementia has been well-described ([@B1]).

MCI (also termed mild neurocognitive disorder according to DSM 5) ([@B2]) is a syndrome in which a person experiencing cognitive symptoms is found to have objective cognitive impairment in one or more domains. While there may be minimal difficulties in instrumental activities of daily living, basic activities of daily living are preserved ([@B3], [@B4]). Early diagnosis of MCI allows for providing advice regarding the possible benefits of interventions, such as cognitive training ([@B5]), aerobic exercise ([@B6]), and planning for the future.

The prevalence of MCI increases with advancing age. The diagnosis of MCI is clinical and is based on Consensus Criteria ([@B7]). The determination of cognitive impairment is based on neuropsychological testing designed to evaluate the main cognitive areas affected by age-related cognitive decline ([@B4]). There is a clear need to develop valid screening tests to ascertain whether cognitive symptoms require further evaluation by neuropsychological testing.

The Montreal Cognitive Assessment (MoCA) Test developed by Nasreddine et al. ([@B8]) has been validated as a reliable cognitive screening test in the older population. This test, which takes only about 10 min to complete, was designed to be effective as a screening instrument for MCI. It has been translated into many languages, and the official website of MoCA includes over 50 translated versions. Some of these translations have been validated, for example those translated to Chinese ([@B9]--[@B18]), Korean ([@B19]), Japanese ([@B20]), Dutch ([@B21]), Spanish ([@B22]), Italian ([@B23]) Portuguese ([@B24], [@B25]), Turkish ([@B26]), Polish ([@B27]), Georgian ([@B28]), Arabic ([@B29], [@B30]) and Hebrew ([@B31]). A comparison of the findings of these validation studies will be presented later in the Discussion section.

The Russian language is the 7th most common spoken language in the world, with about 260 million people speaking the language globally, and about 150 million native Russian speakers (<https://en.wikipedia.org/wiki/Russian_language>). Over one million of the 9 million residents of Israel speak Russian. About 20.9% of citizens aged 65 years and older in Israel define Russian as their mother tongue, and Russian is the most common native language in Israel in this age group ([@B32], [@B33]).

To the best of our knowledge the MoCA questionnaire has not yet been validated in Russian. The aim of the present study was to validate the Russian version of MoCA-Ru in a population of Israelis aged 65 years of age and older who define Russian as their native tongue.

Methods {#s2}
=======

Study Population
----------------

The study population included 160 participants aged 65 years and older with Russian as their mother tongue, 80 with a diagnosis of MCI according to Consensus Criteria ([@B7]) and 80 cognitively asymptomatic controls (AC) based on self-report. According to the Consensus Criteria ([@B7]), MCI was diagnosed when "(a) the person is neither normal nor demented; (b) there is evidence of cognitive deterioration shown by either objectively measured decline over time and/or subjective report of decline by self and/or informant in conjunction with objective cognitive deficits; and ([@B3]) activities of daily living are preserved and complex instrumental functions are either intact or minimally impaired."

Data on the 80 MCI patients were collected from the medical records of the Comprehensive Geriatric Assessment Unit of the Clalit Health Services in Be\'er Sheva. In this Unit, frail community-dwelling older individuals who reside in the Be\'er Sheva region undergo clinical geriatric assessment. The multi-disciplinary staff of the Unit include geriatricians, a nurse, an occupational therapist, a social worker and a dietician. The comprehensive geriatric assessment routinely includes cognitive and functional assessments.

The AC group was a convenience sample recruited by one of the investigators (AV) from a community clinic in Be\'er Sheva. Based on self-reporting of symptoms, inclusion criteria for this group were: (a) no cognitive symptoms suggesting cognitive decline, and (b) no complaint relating to cognition-related difficulties in instrumental activities of daily living (IADL). In both groups, individuals with acute medical conditions, as well as those with bipolar disorder, depression, or schizophrenia, were excluded from the study. All participants provided their informed consent to take part in the study. The study was approved by the Helsinki Committee of the Meir Hospital (Approval \#104/2014C).

Cognitive Evaluation
--------------------

All participants underwent cognitive screening using the Russian version of the MoCA test ([@B8]), as well as cognitive assessment by means of the Russian version of the Neurotrax computerized battery, which has been validated for MCI in other languages ([@B34]).

The MoCA test includes eight parts with a maximum score of 30 (a score of 30 represents the best cognitive state). A score of 26 or above is considered normal in the English language version ([@B8]) and in some of the studies in other languages ([@B12], [@B17], [@B20], [@B21], [@B29], [@B31]). In the present study we used the original version of MoCA in Russian as translated by Posochin O.B. and Smirnov A.J. (<https://www.mocatest.org/wp-content/uploads/2015/tests-instructions/MoCA-Test-Russian_2010.pdf>).

The Neurotrax computerized cognitive assessment battery does not require that the subject has previous computer experience and uses standard neuropsychological tests that were adapted for computer use. The results are grouped into cognitive domains, including memory, attention, visuospatial and executive functions, and a composite score for global cognitive function is calculated. Results are corrected for age and education level according to database norms, with a mean score for each domain being 100, and normal being within one standard deviation (15 points). The test takes about 45 min to administer and requires the use of a mouse and number keyboard keys. It has been translated into various languages, including Russian (<http://www.neurotrax.com>).

Sample Size
-----------

The sample size of 80 in each group was calculated with α = 0.05 and a power of 80% between MoCA and Neurotrax. It was calculated using the Epinfo program 6 (Statcal). We aimed to recruit ninety individuals to each group, anticipating a dropout rate of \~15%.

Statistical Analyses
--------------------

The data were analyzed using the Receiving Operating Characteristic (ROC) method to test the capacity of each research instrument (MoCA compared to Neurotrax as the gold standard) to distinguish between patients with MCI and cognitively asymptomatic older participants. Sensitivity, specificity, positive and negative predictive values and the Youden Index (Sensitivity + Specificity −1) values were computed for various MOCA-Ru cutoff points (≥22, 23, 24, 25, 26). In addition, an ANOVA test was performed to compare continuous variables, and chi square or Fisher exact tests were performed for categorical variables. Statistical significance was set at *P* \< 0.05.

Results {#s3}
=======

Socio-Demographic Characteristics
---------------------------------

The mean age of the study population was 78 ± 6.6 years and 123 (76.9%) were women. On average the participants had immigrated to Israel 20.1 ± 8.8 years earlier. Only 15 participants (9.4%) had \<10 years of education, 52 (32.5%) had 10 years of education and 93 (58.1%) had more than 10 years of education. The socio-demographic data of the two study groups are presented in [Table 1](#T1){ref-type="table"}. The AC group were older and had lived in Israel for a longer period.

###### 

Sociodemographic characteristics of the study population.

                        **AC (*N* = 80)**   **MCI (*N* = 80)**   ***P***
  --------------------- ------------------- -------------------- ----------
  **GENDER**                                                     
  Female                62 (77.5)           61 (76.3)            1.000
  **AGE (YEARS)**                                                
  Mean ± SD             80.1 ± 7.1          75.9 ± 5.3           \<0.0001
  Range                 65-95               65-88                
  **EDUCATION**                                                  
  \<10 years            11 (13.8)           4 (5.0)              0.056
  10 years              29 (36.2)           23 (28.8)            
  More than 10 years    40 (50.0)           53 (66.2)            
  **YEARS IN ISRAEL**                                            
  Mean ± SD             23.9 ± 7.8          16.4 ± 8.1           \<0.0001
  Range                 9-70                1-38                 

*AC, asymptomatic controls; MCI, mild cognitive impairment*.

Score Distributions for MoCA-Ru and Neurotrax
---------------------------------------------

The overall score for MoCA-Ru was higher in the AC group (24.3 ± 3.74 vs. 20.2 ± 3.07, *P* ≥ 0.0001). This difference was true for all the test components except for Memory and Language 2 ([Table 2](#T2){ref-type="table"}). The internal consistency of the MoCA-Ru was limited, with a Cronbach\'s α = 0.65.

###### 

Comparison of the components of the MoCA-Ru, by group.

                            **AC (*N* = 80)**   **MCI (*N* = 80)**   ***P***
  ------------------------- ------------------- -------------------- ----------
  Trail B                   0.49 ± 0.50         0.18 ± 0.38          \<0.0001
  Cube                      0.74 ± 0.44         0.58 ± 0.50          0.031
  Clock                     2.49 ± 0.76         2.13 ± 0.85          0.005
  Naming                    2.96 ± 0.25         2.81 ± 0.45          0.010
  Memory                    1.91 ± 1.76         1.26 ± 1.26          0.008
  Attention 1               1.75 ± 0.49         1.74 ± 0.52          0.876
  Attention 2               0.94 ± 0.24         0.79 ± 0.41          0.006
  Attention 2               2.60 ± 0.81         2.33 ± 0.93          0.047
  Language 1                1.90 ± 0.34         1.24 ± 0.75          \<0.0001
  Language 2                0.29 ± 0.48         0.24 ± 0.43          0.489
  Abstraction               1.87 ± 0.40         1.19 ± 0.83          \<0.0001
  Orientation               5.95 ± 0.27         5.69 ± 0.67          0.001
  **MOCA-Ru total score**   24.3 ± 3.74         20.2 ± 3.07          \<0.0001

*AC, asymptomatic controls; MCI, mild cognitive impairment; MoCA, Montreal Cognitive Assessment*.

The global score of the Neurotrax battery was significantly higher in the AC group than in the MCI group (84.3 ± 10.7 vs. 79.9 ± 8.9, respectively, *P* = 0.005), but the only domain with a significant difference was Memory \[86.7 ± 14.5 (AC) vs. 84.3 ± 10.7 (MCI), *P* \< 0.0001\]. Only six of the 80 participants in the AC group had a Neurotrax global score ≥100. For that reason, in a *post hoc* analysis, a sub-group of 93 participants was created including 52 participants from the MCI group with a global Neurotrax score ≤ 85 (more than one standard deviation below normal) and 41 from the AC group with a global score above 85 (more than one standard deviation below normal). The calculation of power for this sample was 98%. In this sub-group analysis the MoCA-Ru score was 25.66 ± 3.5 in the AC group and 19.4 ± 3.0 in the MCI group (*P* \< 0.0001).

Validity of the MoCA-Ru for Detecting MCI
-----------------------------------------

The sensitivity, specificity, positive, and negative values and the Youden Index for MoCA-Ru were calculated for the entire study population, as well as for the 93 participants in the selected sub-group ([Table 3](#T3){ref-type="table"}).

###### 

Sensitivity, specificity, positive, and negative predictive values and Youden Index for the MoCA-Ru test, with different cutoffs.

  **Cutoff: normal value**                                  **Sensitivity**   **Specificity**   **PPV**   **NPV**   **Youden Index**
  --------------------------------------------------------- ----------------- ----------------- --------- --------- ------------------
  **UNSELECTED STUDY POPULATION (*****N*** **=** **160)**                                                           
  ≥26                                                       1                 0.4               0.63      1         0.4
  ≥25                                                       0.99              0.54              0.68      0.98      0.53
  ≥24                                                       0.83              0.63              0.69      0.78      0.45
  ≥23                                                       0.73              0.72              0.72      0.71      0.46
  **SELECTED SUB-GROUP (*****N*** **=** **93)**                                                                     
  ≥26                                                       1                 0.63              0.78      1         0.63
  ≥25                                                       0.98              0.73              0.83      0.97      0.71
  ≥24                                                       0.91              0.78              0.85      0.87      0.69
  ≥23                                                       0.85              0.81              0.85      0.81      0.66

*PPV, positive predictive value; NPV, negative predictive value; MoCA, Montreal Cognitive Assessment*.

In the unselected population of 160 participants the normal optimal cut-off for the MoCA-Ru with the highest Youden Index was ≥25, with a sensitivity of 0.99, but with a low specificity of 0.54. In the selected group of 93 participants the optimal cut-off for MoCA-Ru was similarly ≥25, with higher specificity (0.73) and similar sensitivity (0.98).

In the ROC curve analysis of the MoCA-Ru score, the area under the curve (AUC) was 0.81 for all subjects and 0.91 for the selected population, confirming that the test has a good discriminating capacity for differentiating participants with MCI from asymptomatic controls ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}).

![Receiver-operator characteristics curves (ROC) of the MoCA-Ru test in an unselected study population (cut-off 25).](fmed-07-00447-g0001){#F1}

![Receiver-operator characteristics curves (ROC) of the MoCA-Ru test in a selected study population (cut-off 25).](fmed-07-00447-g0002){#F2}

Discussion {#s4}
==========

The results of the present study show that the MoCA-Ru test has good discriminating capacity for differentiating participants with MCI from cognitively asymptomatic controls. In contrast to the original English version of the MoCA ([@B8]) in which the normal cut-off value was set at ≥26, the suggested cut-off value in our study is ≥25.

[Table 4](#T4){ref-type="table"} summarizes findings from previous studies that have evaluated the validity of MoCA among populations from various countries in different languages. It can be seen that the cut-off value varies between studies. A meta-analysis that included nine studies ([@B37]) showed that a cut-off of ≥23 had the best diagnostic accuracy.

###### 

Comparison of versions of the MoCA, by language.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Language**   **Country**   **First author**                 **Year of publication**   **Normal cut-off**         **Sensitivity**   **Specificity**   **AUC**   **Cronbach\'s alpha**
  -------------- ------------- -------------------------------- ------------------------- -------------------------- ----------------- ----------------- --------- -----------------------
  Arabic         Egypt         Rahman and El Gaafary ([@B29])   2009                      ≥26                        0.923             0.857             NR        0.83

  Chinese        China         Zhao et al. ([@B18])             2011                      ≥24                        0.772             0.901             0.882     0.889

  Chinese        China         Lu et al. ([@B11])               2011                      Adjusted for education:\   0.805             0.825             0.899     0.85
                                                                                          Illiterate ≥ 14;\                                                        
                                                                                          1--6 years ≥ 20;\                                                        
                                                                                          ≥ 7 years ≥ 25                                                           

  Chinese        Hong Kong     Yeung et al. ([@B16])            2014                      ≥22                        0.828             0.735             0.829     0.767

  Chinese        Singapore     Ng et al. ([@B13])               2015                      GRP sample= ≥23            0.65              0.55              0.63      NR

                                                                                          NNI sample= ≥29            0.64              0.36              0.65      NR

  Chinese        China         Yu et al. ([@B17])               2013                      ≥22                        0.687             0.639             0.71      0.88

  Chinese        Singapore     Ng et al. ([@B12])               2013                      ≥26                        0.96              0.3                         NR

  Chinese        Hong Kong     Chu et al. ([@B35])              2014                      ≥23                        0.78              0.73              0.85      0.85

  Chinese        Singapore     Dong et al. ([@B9])              2013                      ≥20                        0.8               0.92              0.94      NR

  Chinese        China         Hu et al. ([@B10])               2013                      ≥27                        0.92              0.85              0.928     0.867

  Chinese        China         Tan et al. ([@B14])              2014                      Adjusted for age:                                              0.937     0.953

                                                                                          60--79 years ≥26           0.858             0.854                       

                                                                                          80--89 years ≥25\          0.853             0.963                       
                                                                                          ≥ 90 years ≥24                                                           

                                                                                                                     0.903             0.969                       

  Chinese        Taiwan        Tsai et al. ([@B15])             2016                      ≥24                        0.88              0.74              0.91      NR

  Dutch          Nederland     Thissen et al. ([@B21])          2010                      ≥26                        0.72              0.73              NR        0.69

  English        USA           Goldstein et al. ([@B36])        2014                      ≥25                        0.95              0.63              0.79      NR

  English        Canada        Nasreddine et al. ([@B8])        2005                      ≥26                        0.9               0.87              NR        0.83

  Georgian       Georgia       Janelidze et al. ([@B28])        2017                      ≥22                        1.0               0.69              0.88      0.92

  Hebrew         Israel        Lifshitz et al. ([@B31])         2012                      ≥26                        0.946             0.763             0.963     NR

  Italian        Italy         Bosco et al. ([@B23])            2017                      ≥20                        0.692             0.585             0.685     NR

  Japanese       Japan         Fujiwara et al. ([@B20])         2010                      ≥26                        0.93              0.89              0.95      0.74

  Korean         South Korea   Lee et al. ([@B19])              2008                      ≥23                        0.89              0.84              0.94      0.86

  Polish         Poland        Magierska et al. ([@B27])        2012                      ≥25                        0.809             0.54              0.74      NR

  Portuguese     Portugal      Freitas et al. ([@B24])          2013                      ≥22                        0.81              0.77              0.856     0.9

  Portuguese     Brazil        Memória et al. ([@B25])          2013                      ≥25                        0.81              0.77              0.82      0.75

  Russian        Israel        Present study                                              ≥25                        0.99              0.54              0.81      0.65

  Spanish        Colombia      Gil et al. ([@B22])              2015                      ≥23                        0.89              0.798             0.93      0.846

  Turkish        Turkey        Kaya et al. ([@B26])             2014                      Adjusted for\                                                  0.846     0.81
                                                                                          education:                                                               

                                                                                          ≤ 5 years≥18               0.67              0.83                        

                                                                                          6-12 years≥21              0.73              0.85                        

                                                                                          ≥12 years≥23               0.81              0.86                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*GRP, Gerontology Research Program; NNI, National Neuroscience Institute; NR, Not reported*.

A clear advantage of our study is that it is the first study to evaluate the validity of MoCA in a Russian speaking population. However, our study has clear limitations, which raise the question as to the generalizability of the study results. An important limitation is that the methodology of validation of the MoCA that we used in our study differed from that used for validation in a number of other languages. The majority of studies ([@B9]--[@B12], [@B14]--[@B20], [@B22], [@B24]--[@B28], [@B30]) included subjects with either MCI or dementia as well as controls. In contrast, as is the case with some of the other reported studies ([@B13], [@B23], [@B29], [@B31]), our study compared only subjects with MCI to a control group. However, it is important to note that in the original validation study of the MoCA, the investigators found similar results for both the MCI and dementia groups ([@B8]).

Another major limitation of our study is the choice of a group of controls who were cognitively asymptomatic based on self-report alone. While the subjects were diagnosed with MCI based on clinical evaluation, the asymptomatic control group did not undergo formal cognitive evaluation prior to inclusion in the study. This is in contrast to many of the studies where the control group included those with "normal cognition" based on an absence of cognitive symptoms as well as preserved function on cognitive testing ([@B9]--[@B20], [@B31]). Nevertheless, some studies did include a group of asymptomatic controls with normal cognitive screening ([@B23], [@B28]--[@B30]) but no formal cognitive evaluation.

It is important to note that the Neurotrax global score (84.3 ± 10.7) of the control group raises the possibility that some of the participants indeed had cognitive impairment beyond the level anticipated for their age and education level. We thus performed a sub-group analysis to include only cognitively normal controls based on Neurotrax findings compared to those with MCI. In this analysis the normal cut-off for the MoCA-Ru tests remained at ≤ 25, with improved specificity, supporting the validity of our findings. The internal consistency of the MoCA-Ru in our study was lower than in most of the studies listed in [Table 4](#T4){ref-type="table"}.

This convenience sample of asymptomatic controls was also older than our subjects with MCI. However, it is important to emphasize that Neurotrax scores are corrected for age and education level. Also, since the prevalence of MCI increases with age, the older age of the controls actually strengthens our findings.

Many of the studies evaluating different language versions of the MoCA utilized neuropsychological batteries ([@B9], [@B11], [@B14], [@B16], [@B19], [@B22], [@B24], [@B26]) while others used the MMSE with the Clinical Dementia Rating Scale (CDR) Scale ([@B12], [@B15], [@B17], [@B27], [@B30]) or even the MMSE alone ([@B23], [@B28]). In our study we used the Neurotrax computerized cognitive assessment battery, which was also used to validate the Hebrew version of the MoCA ([@B31]), and which has been shown to be reliable for determining the presence of MCI ([@B34]).

Our optimal normal cut-off level was ≥25, which is slightly lower than that of ≥26 found by Nasreddine et al. ([@B8]). A possible explanation for this finding may be related to the age of the participants. In our study, the age of the participants was relatively high compared to other studies in this field ([Table 4](#T4){ref-type="table"}). There is no consensus as to the effect of age on the results of the MoCA test. In some studies, an association with age was found ([@B9], [@B11]--[@B14], [@B26]), while others did not find such an association ([@B10], [@B22], [@B35]). The association between MoCA and education level has been described ([@B9]--[@B14], [@B16], [@B22], [@B26], [@B35]), with a positive association found between education levels and the MoCA score ([@B25]). In the present study \<10% of the participants had an education level lower than 10 years (which is equivalent to high school education in the former Soviet Union). On comparing our study to those in which the study population was well-educated, the optimal normal cut-off was ≥26, as found in the study by Nasreddine et al. ([@B8]) Thus, for example, in the study conducted in Spanish in Colombia by Gil et al. ([@B22]) where the normal cut-off was ≥26, the sensitivity of MoCA was 0.99 and the specificity was 0.52, but when the cut-off was set at ≥23 the sensitivity dropped to 0.89 while the specificity increased to 0.79. In the study by Goldstein et al. ([@B36]) among African Americans the mean education level was 13.4 years in the MCI group and 10.9 in the control group. At a normal cut-off of ≥26 the sensitivity of MoCA was 1.0 with a specificity of 0.4, while at ≥25 the sensitivity was 0.95 and the specificity 0.63.

In a study from Georgia ([@B28]), the mean education level was 11.5 years in the MCI group and 11.6 years in the control group. At the recommended cut-off value of ≥26 the sensitivity of MoCA was 1.0 and the sensitivity was 0.44, but when the cut-off was set at ≥22 the specificity increased to 0.69 without any change in sensitivity (1.0). It is important to note that it is appropriate to compare the results of the Georgian study with those of the present study not only since the populations in both studies were well-educated, but also because the two populations were composed of former residents of the USSR who received an education in schools with similar curricula.

A clear advantage of our study is that it is the first study to evaluate the validity of MoCA in a Russian speaking population. However, this study has clear limitations. The major limitation of the study, which was already discussed in detail above, was that the participants in the control group did not undergo a comprehensive cognitive, affective, and functional assessment, and that their eligibility was based on self-reported normal cognitive and instrumental function. We can thus not exclude the possibility that subjects in the control group may indeed have suffered cognitive impairment. As well, the participants in the control group were recruited from community clinics and not at random. All these factors raise the question as to the generalizability of the study results. Several variables were not collected in the control group. For example, we do not have data on chronic co-morbidity or medical treatment for these participants, so we could not compare the two study groups beyond basic socio-demographic details.

Another limitation of the present study is related to the optimal cut-off, which was determined on the basis of the data analyses. This way of determining the optimal cut-off can increase the risk for bias ([@B38]) and could lead to an overestimation of sensitivity and specificity, especially in small studies ([@B39]).

In conclusion, we found the Russian language version of the MoCA test to be useful as a screening tool for MCI. Further studies should aim to further validate this instrument and to determine the optimal normal cut-off value for MoCA-Ru in the older population with impaired cognitive function.
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